Fonar Corporation (NASDAQ:FONR) — Market Cap & Net Worth
Market Cap & Net Worth: Fonar Corporation (FONR)
Fonar Corporation (NASDAQ:FONR) has a market capitalization of $117.84 Million ($117.84 Million) as of September 20, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #18666 globally and #4335 in its home market, demonstrating a 0.95% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Fonar Corporation's stock price $19.09 by its total outstanding shares 6173008 (6.17 Million). Also see Fonar Corporation total assets for a full breakdown of the balance sheet.
Fonar Corporation Market Cap History: 2015 to 2026
Fonar Corporation's market capitalization history from 2015 to 2026. Data shows growth from $106.55 Million to $117.84 Million (0.85% CAGR). Also see Fonar Corporation (FONR) cash conversion ratio for how efficiently the company converts equity into cash flow.
Index Memberships
Fonar Corporation is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.65 Trillion | 0.00% | #526 of 976 |
|
NASDAQ Composite
IXIC
|
$42.12 Trillion | 0.00% | #1811 of 3165 |
Weight: Fonar Corporation's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Fonar Corporation Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Fonar Corporation's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check FONR share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
1.10x
Fonar Corporation's market cap is 1.10 times its annual revenue
Latest Price to Earnings (P/E) Ratio
13.75x
Fonar Corporation's market cap is 13.75 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $118.21 Million | $73.37 Million | $15.72 Million | 1.61x | 7.52x |
| 2017 | $150.31 Million | $78.04 Million | $19.62 Million | 1.93x | 7.66x |
| 2018 | $124.94 Million | $81.52 Million | $21.23 Million | 1.53x | 5.88x |
| 2019 | $121.55 Million | $87.19 Million | $15.32 Million | 1.39x | 7.94x |
| 2020 | $107.16 Million | $85.69 Million | $8.24 Million | 1.25x | 13.00x |
| 2021 | $90.00 Million | $89.93 Million | $10.21 Million | 1.00x | 8.82x |
| 2022 | $103.40 Million | $97.59 Million | $12.44 Million | 1.06x | 8.31x |
| 2023 | $120.74 Million | $98.65 Million | $9.38 Million | 1.22x | 12.88x |
| 2024 | $93.46 Million | $102.88 Million | $10.57 Million | 0.91x | 8.84x |
| 2025 | $114.57 Million | $104.35 Million | $8.33 Million | 1.10x | 13.75x |
Competitor Companies of FONR by Market Capitalization
Companies near Fonar Corporation in the global market cap rankings as of September 20, 2026. Review FONR intangible-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Fonar Corporation by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #89 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #160 globally with a market cap of $149.61 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #475 globally with a market cap of $57.91 Billion USD ( CN¥395.72 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #578 globally with a market cap of $47.01 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #89 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $651.45 |
| #160 | Danaher Corporation | NYSE:DHR | $149.61 Billion | $211.81 |
| #475 | WuXi AppTec Co Ltd | SHG:603259 | $57.91 Billion | CN¥160.00 |
| #578 | Natera Inc | NASDAQ:NTRA | $47.01 Billion | $369.39 |
Fonar Corporation Historical Marketcap From 2015 to 2026
Between 2015 and today, Fonar Corporation's market cap moved from $106.55 Million to $ 117.84 Million, with a yearly change of 0.85%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $117.84 Million | +2.86% |
| 2025 | $114.57 Million | +22.59% |
| 2024 | $93.46 Million | -22.60% |
| 2023 | $120.74 Million | +16.78% |
| 2022 | $103.40 Million | +14.88% |
| 2021 | $90.00 Million | -16.01% |
| 2020 | $107.16 Million | -11.83% |
| 2019 | $121.55 Million | -2.72% |
| 2018 | $124.94 Million | -16.88% |
| 2017 | $150.31 Million | +27.15% |
| 2016 | $118.21 Million | +10.95% |
| 2015 | $106.55 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 20th, 2026 the market cap of Fonar Corporation was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $117.84 Million USD |
| MoneyControl | $117.84 Million USD |
| MarketWatch | $117.84 Million USD |
| marketcap.company | $117.84 Million USD |
| Reuters | $117.84 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Fonar Corporation
FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments: Medical Equipment, and Physician Management and Diagnostic Services. The company of… Read more